Published in Int J Nanomedicine on August 11, 2014
BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo. Drug Des Devel Ther (2015) 0.77
Nanochelating based nanocomplex, GFc7, improves quality and quantity of human mesenchymal stem cells during in vitro expansion. Stem Cell Res Ther (2015) 0.75
The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med (2008) 2.15
Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim Biophys Acta (1980) 1.97
Oligodendrocytes and myelination: the role of iron. Glia (2009) 1.90
Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry (1988) 1.69
Melanoma complicating treatment with natalizumab for multiple sclerosis. N Engl J Med (2008) 1.69
The history of multiple sclerosis: the changing frame of the disease over the centuries. J Neurol Sci (2009) 1.59
Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol (2004) 1.44
Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol (2013) 1.43
A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci (1995) 1.41
Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal (2010) 1.27
New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab. Lancet Neurol (2009) 1.15
Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm (Vienna) (2010) 1.15
Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 mice. Histochem Cell Biol (2010) 1.02
Radical chemistry of epigallocatechin gallate and its relevance to protein damage. Arch Biochem Biophys (2003) 1.01
Sudden unexpected death on fingolimod. Mult Scler (2012) 1.00
Protective autoimmunity in the nervous system. Pharmacol Ther (2008) 1.00
Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci (1998) 0.98
Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci (2013) 0.97
Antioxidant properties and neuroprotective effects of isocampneoside II on hydrogen peroxide-induced oxidative injury in PC12 cells. Food Chem Toxicol (2013) 0.97
Smart nanomaterials. ACS Nano (2008) 0.94
Challenges associated with metal chelation therapy in Alzheimer's disease. J Alzheimers Dis (2009) 0.93
Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents. Prog Neurobiol (2007) 0.92
The genetics of multiple sclerosis: review of current and emerging candidates. Appl Clin Genet (2013) 0.91
Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmun Rev (2011) 0.91
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J Neuroimmunol (2000) 0.91
Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase. Mol Cell Biochem (2009) 0.91
(-)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injury. Neurochem Int (2013) 0.90
Analyzing the behavior of a porous nano-hydroxyapatite/polyamide 66 (n-HA/PA66) composite for healing of bone defects. Int J Nanomedicine (2014) 0.88
Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res (2007) 0.88
Antioxidant therapy in multiple sclerosis. Immunopharmacol Immunotoxicol (2009) 0.87
Multiple sclerosis: an autoimmune disease of multifactorial etiology. Curr Opin Immunol (1992) 0.87
Therapeutic potential of iron chelators in diseases associated with iron mismanagement. J Pharm Pharmacol (2006) 0.86
Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein. FEBS Lett (1994) 0.86
Decreased production of TNF-alpha by lymph node cells indicates experimental autoimmune encephalomyelitis remission in Lewis rats. Mem Inst Oswaldo Cruz (2010) 0.85
Anti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic system. Neuropathol Appl Neurobiol (2010) 0.84
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis. Front Physiol (2013) 0.83
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis. Mol Immunol (2013) 0.82
The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Neuroimmunomodulation (2010) 0.81
Cortical and subcortical T2 shortening in multiple sclerosis. AJNR Am J Neuroradiol (1997) 0.81
Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis. Clin Immunol (2011) 0.81
Oxidative stress induced by iron released from transferrin in low pH peritoneal dialysis solution. Nephrol Dial Transplant (2004) 0.80
Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J Pharm Sci (2002) 0.80
Interferon beta treatment in relapsing-remitting multiple sclerosis. A review. Clin Neurol Neurosurg (2002) 0.80
The protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber Cucumaria frondosa on oxidative stress in PC12 cells and SAMP8 mice. Neurochem Int (2013) 0.80
Effect of intranasal administration of Semliki Forest virus recombinant particles expressing interferon-β on the progression of experimental autoimmune encephalomyelitis. Mol Med Rep (2011) 0.77
Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats. J Neuroimmunol (2006) 0.76
The Evaluation of Multiple Sclerosis Dispersal in Iran and Its Association with Urbanization, Life Style and Industry. Iran J Public Health (2015) 0.92
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis. Neuroimage (2013) 0.82
The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine. Vaccine (2013) 0.80
Vitamin D and multiple sclerosis. Iran J Neurol (2014) 0.79
Effect of estrogen on Th1, Th2 and Th17 cytokines production by proteolipid protein and PHA activated peripheral blood mononuclear cells isolated from multiple sclerosis patients. Arch Med Res (2014) 0.79
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study. J Neurol Sci (2015) 0.78
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes. Life Sci (2015) 0.78
BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo. Drug Des Devel Ther (2015) 0.77
The role of cerebellar abnormalities in neuromyelitis optica--a comparison with multiple sclerosis and healthy controls. Mult Scler (2014) 0.76
Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns. PLoS One (2016) 0.75
Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls. Iran J Neurol (2015) 0.75
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis. Iran J Allergy Asthma Immunol (2016) 0.75
Growth Performance, Mineral Digestibility, and Blood Characteristics of Ostriches Receiving Drinking Water Supplemented with Varying Levels of Chelated Trace Mineral Complex. Biol Trace Elem Res (2017) 0.75
Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis. Eur Neurol (2017) 0.75
Waterpipe smoking associated with multiple sclerosis: A population-based incident case-control study. Mult Scler (2016) 0.75
TLc-A, the leading nanochelating-based nanochelator, reduces iron overload in vitro and in vivo. Int J Hematol (2016) 0.75
Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran. Iran J Public Health (2017) 0.75
Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. J Clin Neurosci (2019) 0.75